Open access
Open access
Powered by Google Translator Translator

Onco-hematology

Assessment of arsenic trioxide and all-trans retinoic acid for the treatment of pediatric acute promyelocytic leukemia.

14 Nov, 2021 | 19:32h | UTC

Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia: A Report From the Children’s Oncology Group AAML1331 Trial – JAMA Oncology

News release: Drug combination helps children with acute promyelocytic leukemia avoid conventional chemotherapy – NIH News Releases

 

Commentary on Twitter

 


Cluster RCT: In older adults with advanced cancer, a geriatric assessment program reduced the toxic effects of cancer treatment.

5 Nov, 2021 | 09:48h | UTC

Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study – The Lancet

News Release: Less Chemotherapy, Personalized Care: Wilmot Study Reinforces Major Strides in Geriatric Oncology – University of Rochester Medical Center

Related:

RCT: A geriatric assessment–driven intervention can reduce chemotherapy-related toxic effects in older adults with cancer.

Perspective: A Cancer Care Approach Tailored to The Elderly May Have Better Results

 

Commentary from the author on Twitter (thread – click for more)

 


CDC Guidance: Immunocompromised may need a fourth Covid-19 shot.

4 Nov, 2021 | 10:06h | UTC

Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States – Centers for Disease Control and Prevention

Commentaries:

Immunocompromised may need a fourth Covid-19 shot, CDC says – CNN

Some immunocompromised people can receive a 4th Covid shot, CDC says – NBC News

 


ASCO Guideline Update: Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy.

2 Nov, 2021 | 02:51h | UTC

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update – Journal of Clinical Oncology

 


ASCO Guideline: Management of immune-related adverse events in patients treated with Chimeric Antigen Receptor T-Cell Therapy.

2 Nov, 2021 | 02:47h | UTC

Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline – Journal of Clinical Oncology

 


RCT: Daratumumab, lenalidomide, and dexamethasone vs. lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma.

28 Oct, 2021 | 09:53h | UTC

Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial – The Lancet Oncology

Commentary: Overall Survival in the MAIA Trial: Daratumumab, Lenalidomide, and Dexamethasone for Newly Diagnosed Transplant-Ineligible Patients With Multiple Myeloma – The ASCO Post

 


NCCN Guideline: Cancer-Associated Venous Thromboembolic Disease.

21 Oct, 2021 | 10:06h | UTC

Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Comprehensive Cancer Network

Related:

ASH 2021 guidelines for prevention and treatment of venous thromboembolism in patients with cancer

Review: venous and arterial thromboembolism in patients with cancer.

Systematic Review: Does testing for cancer in people with unprovoked blood clots in the legs and lungs reduce cancer- and blood clot-related death and illness?

M-A: Extended thromboprophylaxis after hospital discharge for medically ill patients with cancer – Extended thromboprophylaxis is not associated with a reduced rate of venous thromboembolic events and is associated with increased risk of hemorrhage

Systematic review: Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy

 


Systematic Review: Direct oral anticoagulants (DOACs) may be beneficial for people being treated for cancer who have no therapeutic or prophylactic indication for anticoagulation.

14 Oct, 2021 | 09:44h | UTC

Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation – Cochrane Library

 


State of the Art Review: Advances in acute myeloid leukemia.

8 Oct, 2021 | 10:05h | UTC

Advances in acute myeloid leukemia – The BMJ

 

Commentary on Twitter

 


Series from the Lancet journals: Hematological malignancies in older people.

6 Oct, 2021 | 08:47h | UTC

Homepage: Haematological malignancies in older people – The Lancet Haematology

Commentary: Living longer and better with haematological malignancies: a promise for older adults too? (free registration required)

A comprehensive approach to therapy of haematological malignancies in older patients (free registration required)

Frailty assessment in the care of older people with haematological malignancies

Haematopoietic stem-cell transplantation in older adults: geriatric assessment, donor considerations, and optimisation of care (free registration required)

Palliative care of patients with haematological malignancies: strategies to overcome difficulties via integrated care

Implementation of geriatric haematology programmes for the treatment of older people with haematological malignancies in low-resource settings

 


Podcast: Neutropenic Fever.

28 Sep, 2021 | 08:52h | UTC

#288 LIVE! Neutropenic Fever featuring Dr. Susan Seo – The Curbsiders

 


Guideline: Acute abdomen in the immunocompromised patient.

16 Aug, 2021 | 01:00h | UTC

Acute abdomen in the immunocompromised patient: WSES, SIS-E, WSIS, AAST, and GAIS guidelines – World Journal of Emergency Surgery

 


Antibody response to COVID-19 vaccination in adults with hematologic malignant disease.

13 Aug, 2021 | 09:47h | UTC

Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease – JAMA Oncology

 

Commentary on Twitter

 


Guideline: Laboratory detection and initial diagnosis of monoclonal gammopathies.

6 Aug, 2021 | 09:56h | UTC

Laboratory Detection and Initial Diagnosis of Monoclonal Gammopathies: Guideline From the College of American Pathologists in Collaboration With the American Association for Clinical Chemistry and the American Society for Clinical Pathology – Archives of Pathology & Laboratory Medicine

 


European PanCare Follow Up Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer.

1 Aug, 2021 | 23:59h | UTC

European PanCare Follow Up Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer – European Journal of Cancer

 


Survival outcomes for cancer types with the highest death rates for adolescents and young adults, 1975-2016.

1 Aug, 2021 | 23:58h | UTC

Survival outcomes for cancer types with the highest death rates for adolescents and young adults, 1975-2016 – Cancer

Commentary: Survival Trends for Adolescents and Young Adults With Cancer: 40-Year Analysis – The ASCO Post

 


RCT: Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease.

16 Jul, 2021 | 10:37h | UTC

Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease – New England Journal of Medicine

 


Acute promyelocytic leukemia current treatment algorithms.

15 Jul, 2021 | 09:01h | UTC

Acute promyelocytic leukemia current treatment algorithms – Blood Cancer Journal

 


Perspective | Should People With Immune Problems Get Third Vaccine Doses?

8 Jul, 2021 | 09:07h | UTC

Should People With Immune Problems Get Third Vaccine Doses? – The New York Times (a few articles per month are free)

Related: [Preprint] 3rd AstraZeneca shot gives strong immunity. AND Case series: Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients.

 


Study Commentary: Febrile Neutropenia – Procalcitonin vs. MASCC Score.

8 Jul, 2021 | 08:57h | UTC

Febrile Neutropenia – Procalcitonin vs MASCC Score – Journal Feed

Original study: Prognostic Value of Serum Procalcitonin Levels in Patients With Febrile Neutropenia Presenting to the Emergency Department – The Journal of Emergency Medicine

 


RCT: Daratumumab-based treatment for immunoglobulin light-chain amyloidosis.

7 Jul, 2021 | 08:44h | UTC

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis – New England Journal of Medicine

 


AHA Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis.

5 Jul, 2021 | 01:41h | UTC

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis:

Part 1 of 2—Evidence Base and Standardized Methods of Imaging

Part 2 of 2—Diagnostic Criteria and Appropriate Utilization – Circulation: Cardiovascular Imaging

 


Review: venous and arterial thromboembolism in patients with cancer.

16 Jun, 2021 | 08:20h | UTC

Venous and Arterial Thromboembolism in Patients With Cancer: JACCCardioOncology State-of-the-Art Review

Summary: Venous and Arterial Thromboembolism in Patients With Cancer – American College of Cardiology

 


Update on the diagnosis and treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome.

6 Jun, 2021 | 23:37h | UTC

Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review – JAMA Oncology (free for a limited period)

 


Guideline | Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors.

31 May, 2021 | 08:09h | UTC

Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO) – Annals of Hematology

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.